Recurrence: all 3,523 studies

Page 28 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple MyelomaCompletedNCT02144038Phase 1
• Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.ColiCompletedNCT02142751Phase 3
• UARK 2014-08 A Phase II Open-Label, Multiple-Dose, Single Agent Study to Evaluate the Overall Response Rate of Orally Administered TrametinibWithdrawnNCT02140840Phase 2
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL PatientsTerminatedNCT02137889Phase 1
• Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T LymphocytesStatus unknownNCT02134262Phase 1/2
• (PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic CancerTerminatedNCT02132403Phase 1
• Modified Limberg Procedure Versus Lateral Advancement Flap With Burrow's Triangle Procedure in the Treatment of Pilonidal SinusCompletedNCT02116738Not applicable
• A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple MyelomaCompletedNCT02116569Phase 1
• 2-octyl Cyanoacrylate for Closure of Urethrocutaneous Fistula.CompletedNCT02115191Phase 3
• Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCompletedNCT02115074Phase 1
• Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in MyelomaWithdrawnNCT02114502Phase 2
• Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer PatientsCompletedNCT02111954
• Acupuncture in Persistent Atrial FibrillationStatus unknownNCT02110537Not applicable
• Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian CarcinomaTerminatedNCT02107378Phase 2
• Effect of Anti-craving Medication on Cognitive Functions in Alcohol Dependence: an ERP StudyCompletedNCT02107352
• Short Message System (SMS) Monitoring Intended for the Suicidal PatientsCompletedNCT02106949Phase 3
• A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWithdrawnNCT02105350Phase 1
• Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple MyelomaCompletedNCT02103335Phase 1
• HPV-test, Cervical Cancer and Follow-upStatus unknownNCT02096016
• A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's LymphomaWithdrawnNCT02095574Phase 1
• Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical CarcinomaCompletedNCT02083211Phase 3
• IPC Status as a Surgical Quality Marker in Rectal Cancer SurgeryStatus unknownNCT02081547
• A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALLCompletedNCT02081378Phase 1
• The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular HolesStatus unknownNCT02081170Not applicable
• "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute LeukemiaCompletedNCT02074657Phase 2
• Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT02072967
• A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of GenesCompletedNCT02069730Not applicable
• Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CAStatus unknownNCT02064725Phase 2
• Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/IrinotecanTerminatedNCT02060955Phase 2
• Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)Status unknownNCT02060656Phase 2
• Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial FibrillationCompletedNCT02059369Not applicable
• Therapy of Atrial Flutter by Afib AblationStatus unknownNCT02051621Not applicable
• Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and CyclophosphamideCompletedNCT02046915Phase 2
• Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency AblationStatus unknownNCT02046356
• A Phase I Study of IGN523 in Subjects With Relapsed or Refractory AMLCompletedNCT02040506Phase 1
• Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity InterventionStatus unknownNCT02035631Phase 3
• Immunotherapy Study for Metastatic Renal Cell CancerCompletedNCT02035358Phase 1
• Decrease in Circulating Tumour Cell Count Reflects the Effectiveness of Postoperative Adjuvant Transarterial Chemoembolization (TACE) in Preventing Hepatocellular Carcinoma RecurrenceCompletedNCT02032368Not applicable
• A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast CancerStatus unknownNCT02030678Phase 2
• RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVERCompletedNCT02029729Phase 1
• AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine ChemotherapyStatus unknownNCT02024308Phase 4
• Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum DisordersStatus unknownNCT02021825Phase 4
• Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.CompletedNCT02017457Phase 2
• Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain TumorsStatus unknownNCT02015728Not applicable
• Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane TransplantationStatus unknownNCT02015000Not applicable
• Rifaximin for the Secondary Prevention of Spontaneous Bacterial Peritonitis Recurrence in Cirrhotic PatientsWithdrawnNCT02011841Phase 3
• The Effect of Vitamin D3 to Maintain Surgical Remission in Postoperative Crohn's DiseaseCompletedNCT02010762Phase 4
• MetronomIc CApecitabine and DOcetaxel as Second-line Chemotherapy for Advanced Gastric CancerStatus unknownNCT02007148Phase 2
• BNCT and IG-IMRT for Recurrent Head and Neck CancerStatus unknownNCT02004795Phase 1/2
• RX-5902 Treatment of Subjects With Triple Negative Breast CancerTerminatedNCT02003092Phase 1/2
• 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in ChildrenStatus unknownNCT01995721Phase 3
• Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With CancerCompletedNCT01989845Phase 4
• Efficacy of Propranolol Treatment to Prevent Melanoma ProgressionSuspendedNCT01988831Phase 2
• CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITISCompletedNCT01980745Phase 4
• Dovitinib (TKI258) in the Treatment of Patients With Relapsed GlioblastomaStatus unknownNCT01972750Phase 1
• An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's LymphomaCompletedNCT01969695Phase 1
• A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199WithdrawnNCT01969682Phase 1
• A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199CompletedNCT01969669Phase 1
• ANG1005 in Patients With Recurrent High-Grade GliomaCompletedNCT01967810Phase 2
• Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell LymphomaCompletedNCT01965119Phase 2
• C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progressionWithdrawnNCT01961934Phase 2/3
• Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell TransplantCompletedNCT01959477Early Phase 1
• Virus DNX2401 and Temozolomide in Recurrent GlioblastomaCompletedNCT01956734Phase 1
• Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System LymphomaCompletedNCT01956695Phase 2
• A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of RelapseActive, not recruitingNCT01952223Phase 3
• Recurrences After Surgery for Deep Endometriosis Depending on the Involvement of the Surgical Margins in the SpecimenWithdrawnNCT01949597
• Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and LymphomaTerminatedNCT01944982Phase 1/2
• Phase II Study of Vismodegib in Patients With Refractory or Relapsed B-cell Lymphoma or Chronic Lymphocytic LeukemiaTerminatedNCT01944943Phase 2
• Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis TransplantationStatus unknownNCT01941394Phase 2
• Algorithm Guided Treatment Strategies for Bipolar DepressionStatus unknownNCT01938859Phase 4
• Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical SurgeryStatus unknownNCT01936233Phase 3
• Anal Fistula Plug Versus Endorectal Advancement FlapStatus unknownNCT01931371Not applicable
• Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT01924624Not applicable
• A French Multi-centric Atrial Fibrillation Catheter Ablation SurveyStatus unknownNCT01918670
• Maintenance Therapy With Subcutaneous BortezomibCompletedNCT01913730Phase 2
• Study of Association Between Peripheral Immune Cells and Recurrence in Stage II/III Colorectal CancerStatus unknownNCT01911988
• Definitive Therapy for Oligometastatic Solid MalignanciesStatus unknownNCT01898962Phase 2
• Escitalopram, Placebo and tDCS in Depression: a Non-inferiority TrialCompletedNCT01894815Phase 3
• Mesalazine Effects in Sporadic Colorectal Adenoma PatientsCompletedNCT01894685Phase 2
• Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma PatientsStatus unknownNCT01884441Phase 2
• Prognostic Value of CTC in HNSCC PatientsTerminatedNCT01884129
• "Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNCT01883297Phase 1
• Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian CancerTerminatedNCT01881451
• Crohn's Extent of Resection TrialWithdrawnNCT01876264Not applicable
• Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesCompletedNCT01871675Phase 1
• Not Quite Ready to QuitCompletedNCT01866722Not applicable
• Web and Phone Intervention to Maintain Postpartum Tobacco AbstinenceCompletedNCT01864954Not applicable
• Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCCCompletedNCT01864772Phase 2
• iCAT for Recurrent/Refractory/HR Solid TumorsCompletedNCT01853345
• Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWithdrawnNCT01851408Phase 2
• Role of N-Acetylcysteine in Treatment of Bacterial VaginosisStatus unknownNCT01841411Phase 4
• High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin LymphomaActive, not recruitingNCT01840566Phase 1
• An Open Label Treatment Use Protocol for Ibrutinib in Subjects With Relapsed or Refractory Mantle Cell LymphomaApproved for marketingNCT01833039
• VELCADE® Plus Rituximab in Non Hodgkin's Follicular LymphomaCompletedNCT01830465Phase 2
• Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent PatientsCompletedNCT01828866Not applicable
• Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine TherapyCompletedNCT01828346Phase 1/2
• 3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAINActive, not recruitingNCT01822652Phase 1
• IMPROV (Improving the Radical Cure of Vivax Malaria)CompletedNCT01814683Not applicable
• Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian CancerCompletedNCT01809379Phase 2
• Internetbased Relapse Prevention for Partially Remitted DepressionStatus unknownNCT01807988Not applicable

← Recurrence overview